Aug. 9, 2023, 8:33 p.m. | Brigid Bondoc, Wendy Chow

HealthTech Magazine healthtechmagazine.net

Governance over the use of artificial intelligence in regulated environments such as healthcare has been developing in an almost arbitrary manner.
The U.S. Food and Drug Administration has taken the most definitive steps in its publication of the 2021 Artificial Intelligence and Machine Learning Software as a Medical Device Action Plan, which outlined the establishment of “practical oversight” of AI or ML-based Software as a Medical Device. However, the first draft guidance on proposing an approach to support iterative improvement …

5 questions administration artificial artificial intelligence environments food food and drug administration generative governance healthcare intelligence machine machine learning medical medical device publication questions software

More from healthtechmagazine.net / HealthTech Magazine

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US